5 recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Recruiting 5 |
Follow Chronic Obstructive Pulmonary Disease: new trials by email Literature Review of Chronic Obstructive Pulmonary Disease trials Research Report on Chronic Obstructive Pulmonary Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation Budesonide/Glycopyrronium/Formoterol Fumarate, Placebo, Metered dose inhaler - Chronic Obstructive Pulmonary Disease, Hyperinflation | Phase 4 | Recruiting | AstraZeneca | 56 | 2025-11-24 | 2026-09-18 |
| A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease. Dupilumab, Placebo - Chronic Obstructive Pulmonary Disease | Phase 4 | Recruiting | Sanofi | 218 | 2025-09-22 | 2026-10-20 |
| Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels Budesonide - Chronic Obstructive Pulmonary Disease | Phase 4 | Recruiting | Maria Joyera Rodríguez | 135 | 2025-02-12 | 2026-07-20 |
| Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations Azithromycin Pill, Placebo - Chronic Obstructive Pulmonary Disease | Phase 4 | Recruiting | Dr Ian B Wilkinson | 1311 | 2024-03-05 | 2024-04-03 |
| Chronic Airway Disease, Mucus Rheology and Exacerbations Azithropycin according to symptoms, Azithromycin according to rheology or symptoms - Chronic Obstructive Pulmonary Disease | Phase 4 | Recruiting | University Hospital, Montpellier | 72 | 2023-02-03 | 2026-09-24 |
Pulmonary Disease, Chronic Obstructive (5)
Chronic Disease (5) · Disease Attributes (5) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Respiratory Tract Diseases (5)
Budesonide (2) · Azithromycin (1) · Metered Dose Inhalers (1) · dupilumab (1)
AstraZeneca (1) · Dr Ian B Wilkinson (1) · Maria Joyera Rodríguez (1) · Sanofi (1) · University Hospital, Montpellier (1)
United Kingdom (4) · Germany (3) · France (2) · Netherlands (2) · Spain (2) · Argentina (1) · Austria (1) · Brazil (1) · Canada (1) · China (1) · Denmark (1) · Hungary (1) · Italy (1) · Japan (1) · Poland (1)
Ian B Wilkinson (1)
2025 (2), 2023 (1)